Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BYPharmaceuticals (Basel, Switzerland)

Targeting Neuroinflammation After Traumatic Brain Injury: Addressing Sex Differences to Improve Clinical Translation

Related

  1. Dendrimer Delivered shRNA Targeting the CCL20-CCR6 Axis Suppresses Complement-Mediated Microglial Synaptic Pruning and Ameliorates Chronic Neuroinflammation After Repetitive Traumatic Brain Injury
    K. Mayilsamy, P. B. Patel, R. Green +11
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  2. Targeting the RNA regulator HuR in acute traumatic brain injury mitigates secondary injury and improves functional outcome by suppressing neuroinflammation
    P. H. King, M. A. Husain, B. Sheline +7
    bioRxivPreprintCC BYFull textNeurosciencebioRxiv
  3. Sympathetic Modulation of Neuroinflammation by Reserpine Improves Neurogenesis in ICR Mice with Traumatic Brain Injury
    Natalia Ermakova, Edgar Pan, Victoria Skurikhina +5
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Kaempferol attenuates secondary brain injury after traumatic brain injury in mice with reduced neuroinflammation
    Tuo Li, Dianyi Wang, Lei Li +5
    Scientific ReportsPeer-reviewedCC BY 4.0Crossref
  5. In situ delivery of cannabidiol-loaded GelMA sponge attenuates cerebral edema and neuroinflammation in traumatic brain injury
    Hengxi Li, Xinyuan Luo, Yan Cao +8
    Materials today. BioPeer-reviewedCC BY-NC-NDFull textEurope PMC
BibTeX
@article{anon2026targeting,
  title = {{Targeting Neuroinflammation After Traumatic Brain Injury: Addressing Sex Differences to Improve Clinical Translation}},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13708345},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Targeting Neuroinflammation After Traumatic Brain Injury: Addressing Sex Differences to Improve Clinical Translation
PY  - 2026
DA  - 2026/10/01
JO  - Pharmaceuticals (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13708345
SN  - 1424-8247
ER  -